---
figid: PMC7924357__curroncol-28-00064-g001
figlink: pmc/articles/PMC7924357/figure/curroncol-28-00064-f001/
number: F1
caption: Angiogenesis pathways in malignancy and targeted therapies commonly used.
  Monoclonal antibodies including bevacizumab and ramucirumab and tyrosine kinase
  inhibitors including sunitinib, sorafenib, lenvatinib, pazopanib, axitinib, cediranib,
  and cabozantinib have been included (this list is not exhaustive). Receptors including
  VEGFR, c-kit, epidermal growth factor receptor (EGFR), fibroblast growth factor
  receptor (FGFR), and PDGFR are displayed here, but certain medications also target
  other pathways not displayed here such as AXL and RET. The VEGFR pathway intersects
  with multiple cell signaling pathways, including the PI3K/AKT/mTOR pathway. Created
  with Biorender.com.
pmcid: PMC7924357
papertitle: 'Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation:
  A Case Report and Review of the Literature.'
reftext: Lawrence Kasherman, et al. Curr Oncol. 2021 Feb;28(1):661-670.
pmc_ranked_result_index: '50684'
pathway_score: 0.9368138
filename: curroncol-28-00064-g001.jpg
figtitle: Angiogenesis pathways in malignancy and targeted therapies commonly used
year: '2021'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7924357__curroncol-28-00064-g001.html
  '@type': Dataset
  description: Angiogenesis pathways in malignancy and targeted therapies commonly
    used. Monoclonal antibodies including bevacizumab and ramucirumab and tyrosine
    kinase inhibitors including sunitinib, sorafenib, lenvatinib, pazopanib, axitinib,
    cediranib, and cabozantinib have been included (this list is not exhaustive).
    Receptors including VEGFR, c-kit, epidermal growth factor receptor (EGFR), fibroblast
    growth factor receptor (FGFR), and PDGFR are displayed here, but certain medications
    also target other pathways not displayed here such as AXL and RET. The VEGFR pathway
    intersects with multiple cell signaling pathways, including the PI3K/AKT/mTOR
    pathway. Created with Biorender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - KITLG
  - EGF
  - FGF1
  - FGF7
  - FGF8
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF23
  - FGF18
  - FGF20
  - FGF22
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF9
  - FGF17
  - FGF16
  - FGF19
  - FGF21
  - PDGFB
  - KIT
  - EGFR
  - FGFR4
  - FGFRL1
  - FGFR1
  - FGFR3
  - FGFR2
  - PDGFRB
  - PDGFRA
  - AKT2
  - AKT3
  - AKT1
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - H
  - Sunitinib
  - Pazopanib
  - Axitinib
  - Sorafenib
  - Cediranib
  - Lenvatinib
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: SCF
  symbol: SCF
  source: hgnc_alias_symbol
  hgnc_symbol: KITLG
  entrez: '4254'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: PDGFB
  symbol: PDGFB
  source: hgnc_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
- word: c-kit
  symbol: KIT
  source: hgnc_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: P13K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P13K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: P13K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: P13K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: H
  source: MESH
  identifier: D006859
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Pazopanib
  source: MESH
  identifier: C516667
- word: Axitinib
  source: MESH
  identifier: C503983
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: Cediranib
  source: MESH
  identifier: C500926
- word: Lenvatinib
  source: MESH
  identifier: C531958
diseases: []
figid_alias: PMC7924357__F1
redirect_from: /figures/PMC7924357__F1
figtype: Figure
---
